Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claude Negrier

Showing results (31-40 of 61) with videos related to

Pageof 7
Sort By:
Blood|August 4, 2012
Safety and pharmacokinetics of a novel recombinant fusion protein linking coagulation factor IX with albumin (rIX-FP) in hemophilia B patientsElena Santagostino, Claude Negrier, Robert Klamroth, et al.
Critical Care (London, England)|January 12, 2013
A French multicenter randomised trial comparing two dose-regimens of prothrombin complex concentrates in urgent anticoagulation reversalDelphine Kerebel, Luc-Marie Joly, Didier Honnart, et al.
International Journal of Environmental Research and Public Health|January 21, 2022
Haemophilia in France: Modelisation of the Clinical Pathway for PatientsKaren Beny, Benjamin du Sartz de Vigneulles, Florence Carrouel, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|July 5, 2008
An unusual clinical presentation of factor XIII deficiency and issues relating to the monitoring of factor XIII replacement therapyYesim Dargaud, Philippe de Mazancourt, Lucia Rugeri, et al.
Expert Review of Hematology|July 9, 2019
Switching patients in the age of long-acting recombinant products?Miguel Escobar, Elena Santagostino, Maria Elisa Mancuso, et al.
Thrombosis and Haemostasis|March 1, 2005
Evaluation of thrombin generating capacity in plasma from patients with haemophilia A and BYesim Dargaud, Suzette Béguin, Anne Lienhart, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|May 13, 2008
Evaluation of thromboelastography for monitoring recombinant activated factor VII ex vivo in haemophilia A and B patients with inhibitors: a multicentre trialGuy Young, Liselotte S Ebbesen, Dorthe Viuff, et al.
Thrombosis Research|August 23, 2012
Evaluation of a standardized protocol for thrombin generation measurement using the calibrated automated thrombogram: an international multicentre studyYesim Dargaud, Alisa S Wolberg, Roger Luddington, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 20, 2019
REACH: A programme for improving care in haemophiliaYasmin Goga, Rachida Boukari, Meriem Bensadok, et al.
Thrombosis and Haemostasis|October 21, 2020
Pharmacokinetics and Pharmacodynamics of Emicizumab in Persons with Hemophilia A with Factor VIII Inhibitors: HAVEN 1 StudyChristophe Schmitt, Joanne I Adamkewicz, Jin Xu, et al.
Pageof 7

Showing results (31-40 of 61) with videos related to

Sort By:
Pageof 7
Blood|August 4, 2012
Safety and pharmacokinetics of a novel recombinant fusion protein linking coagulation factor IX with albumin (rIX-FP) in hemophilia B patientsElena Santagostino, Claude Negrier, Robert Klamroth, et al.
Critical Care (London, England)|January 12, 2013
A French multicenter randomised trial comparing two dose-regimens of prothrombin complex concentrates in urgent anticoagulation reversalDelphine Kerebel, Luc-Marie Joly, Didier Honnart, et al.
International Journal of Environmental Research and Public Health|January 21, 2022
Haemophilia in France: Modelisation of the Clinical Pathway for PatientsKaren Beny, Benjamin du Sartz de Vigneulles, Florence Carrouel, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|July 5, 2008
An unusual clinical presentation of factor XIII deficiency and issues relating to the monitoring of factor XIII replacement therapyYesim Dargaud, Philippe de Mazancourt, Lucia Rugeri, et al.
Expert Review of Hematology|July 9, 2019
Switching patients in the age of long-acting recombinant products?Miguel Escobar, Elena Santagostino, Maria Elisa Mancuso, et al.
Thrombosis and Haemostasis|March 1, 2005
Evaluation of thrombin generating capacity in plasma from patients with haemophilia A and BYesim Dargaud, Suzette Béguin, Anne Lienhart, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|May 13, 2008
Evaluation of thromboelastography for monitoring recombinant activated factor VII ex vivo in haemophilia A and B patients with inhibitors: a multicentre trialGuy Young, Liselotte S Ebbesen, Dorthe Viuff, et al.
Thrombosis Research|August 23, 2012
Evaluation of a standardized protocol for thrombin generation measurement using the calibrated automated thrombogram: an international multicentre studyYesim Dargaud, Alisa S Wolberg, Roger Luddington, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 20, 2019
REACH: A programme for improving care in haemophiliaYasmin Goga, Rachida Boukari, Meriem Bensadok, et al.
Thrombosis and Haemostasis|October 21, 2020
Pharmacokinetics and Pharmacodynamics of Emicizumab in Persons with Hemophilia A with Factor VIII Inhibitors: HAVEN 1 StudyChristophe Schmitt, Joanne I Adamkewicz, Jin Xu, et al.
Pageof 7